To include your compound in the COVID-19 Resource Center, submit it here.
There were no surprises in data released by FDA and Ilex about ILXO's Clolar clofarabine in advance of Wednesday's Oncologic Drugs Advisory Committee meeting. ODAC's discussion of Clolar is
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury